Back to table of contents

Ambiguous Genitalia

 

This is the subcategory of Disorders of Sex Development (DSD) which presents with abnormalities of the external genitalia.  The incidence of genital anomalies at birth is as high as 1 in 300 births, but the prevalence of complex anomalies with true sexual ambiguity is lower, approximately 1 in 5000.  A newborn with ambiguous genitalia is a diagnostic challenge.  The announcement of the probable sex or use of personal pronouns should be avoided.  The parents should be informed that the child is healthy, but that more tests need to be run before the sex can accurately be determined.  Critical in the sex determination is the ability of the genitalia to function sexually in adulthood.  Therefore assignment of sex and decisions concerning rearing should be postponed until all test results are known.  Continuous psychosocial support for the parents is necessary throughout the process and may be necessary for the family and the child during the child’s development.

 

Chicago Consensus

In 2005 a consensus was reached at a meeting in Chicago regarding the terminology and classification of intersex disorders.  The use of ‘intersex’ would be replaced by ‘disorders of sex development’, defined as ‘a congenital condition in which development of chromosomal, gonadal or anatomical sex is atypical’. The use of ‘hermaphrodite’ and ‘pseudohermaphrodite’ would be replaced by the karyotype and an accurate description of the abnormality.  The karyotype is first identified and then based on the other test results, the diagnoses have been divided into the following categories: disorders of gonadal development, disorders of androgen synthesis, disorders of androgen action, disorders of androgen excess, leydig cell defect, persistent mullerian duct syndrome, defects of mullerian development, non-specific disorder of undermasculinisation, and other.

 


Sex Chromosome DSD

47,XXY (Klinefelter)

45,X (Turner)

45,X/46,XY

46,XX/46,XY

 

46,XY DSD

Disorders of gonadal development

Disorders in androgen synthesis or action

Other

46,XX DSD

Disorders of gonadal development

Androgen Excess

Other

 


 

Which infants should be evaluated?

·      Overt genital ambiguity.

·      Family history of DSD such as complete androgen insensitivity syndrome.

·      Discordance between genital appearance and a prenatal karyotype.

·      Apparent female genitalia with an enlarged clitoris and posterior labial fusion, an inguinal/labial mass.

·      Apparent male genitalia with bilateral undescended testes, a microphallus, proximal hypospadias or distal or mid-shaft hypospadias with undescended testis.

 

Why is an evaluation necessary?

·      To determine the sex of rearing

·      To evaluate for concern of CAH and adrenal insufficiency

·      To determine the etiology and the best long term management

·      To address questions of future fertility, sexual function and tumor development

 

History

·      Family History – parental consanguinity and relatives with ambiguous genitalia, primary amenorrhea, early death, medical issues.  Autosomal recessive pattern may suggest altered steroidogenesis.  X-linked recessive pattern may suggest androgen insensitivity syndrome.

·      Maternal history – medications (androgens-progesterones, danazol, testosterone or endocrine disrupters- phenytoin, aminoglutethimide), virilization before or during pregnancy, prenatal test results.

 

Physical Exam

·      General Exam

o   General health

o   Dysmorphic features

o   Midline defects

o   Hydration

o   Blood pressure

·      Genital Exam

o   Penile/Clitoral length and diameter

o   Gonads – present/absent, size, location

§  ‘Federman’s rule – a gonad felt below the inguinal ligament is a testes until proven otherwise’

o   Urethral opening – hypospadias, epispadias, virilized urogenital sinus

o   Rectal inspection

o   Labiosacral fusion – anogenital ratio (distance between anus and posterior fourchette divided by the distance between the anus and the base of the clitoris) of >0.5 suggests virilization with some posterior labial fusion.

o   External Masculinisation Score – scores scrotal fusion, microphallus, location of urethral meatus and location of each gonad.

 

Initial Laboratory Studies

·      Karyotype

o   Including FISH with SRY probe

·      Serum electrolytes

·      Serum 17 alpha hydroxyprogesterone (17-OHP)

o   Elevated in most common cause of CAH, 21-hydroxylase deficiency

·      Ultrasound of the pelvis/abdomen for mullerian structures

·      Serum anti-mullerian hormone (AMH)

·      Further testing may be necessary depending on karyotype and other laboratory results.  This may include 11-deoxycortisol, cortisol, DHEA, ACTH stimulation test, hCG stimulation test.

 

Sex Chromosome DSD

·      Less likely to present with ambiguous genitalia, mosaic presentations must be considered. 

 

46,XY DSD, Undervirilized Boy

·      Environmental chemicals leading to hypospadias, undescended testes that may not meet full criteria for DSD

·      Congenital adrenal hyperplasia

o   Multiple enzyme deficiencies may cause this.  21 hydroxylase deficiency does not result in genital ambiguity in males, but can lead to death from salt wasting if unrecognized.

·      5 alpha reductase deficiency

·      Androgen insensitivity syndrome or receptor defects (testicular feminization)

·      Gonadal dysgenesis

·      Testicular regression syndromes

 

 46,XX DSD, Virilized Girl

·      Congenital adrenal hyperplasia

o   21 alpha hydroxylase deficiency is the most severe and presents at about two weeks of age with salt wasting and are at risk for adrenal crisis.  21 alpha hydroxylase deficiency and 11 beta hydroxylase deficiency can be excluded with serum 17 hydroxyprogesterone.

·      Gestational androgen excess states such as maternal androgen use, oral contraceptives, polycystic ovarian syndrome, tamoxifen use and androgen secreting tumors

·      Aromatase deficiency leading to estrogen deficiency and androgen excess – may see double virilizing effect – on both mother and child during pregnancy

 

References

·      Ahmed SF, and Rodie M.  Investigation and initial management of ambiguous genitalia.  Best Practice & Research Clinical Endocrinology & Metabolism.  2010; 24 (197-218).

·      Anhalt H, and Hintz R.  Ambiguous Genitalia. Pediatrics in Review. June 1996.

·      Houk C, Levitsky L.  Evaluation of the infant with ambiguous genitalia.  Uptodate. Updated April 2010

·      Huges I.  Disorders of sex development: a new definition and classification.  Best Practice & Research Clinical Endocrinology & Metabolism. 2008; 22 (119-134).

·      McDermott, Frank. Ambiguous Genitalia. PedClerk website.

·      Rosenfield RJ, Lucky AW, Allen TD.  The diagnosis and management of intersex.  Current Problems in Pediatrics. 1980; 10(7).

Back to table of contents